{"log_id": 6769879669136847454, "direction": 0, "words_result_num": 48, "words_result": [{"probability": {"variance": 0.005931, "average": 0.977606, "min": 0.530297}, "location": {"width": 940, "top": 139, "height": 28, "left": 131}, "words": "治疗相关的间质性肺病肺炎。在这些病例中,有14例(1%)为≥3和5级,且是致命的。在中国大陆患"}, {"probability": {"variance": 0.003104, "average": 0.979913, "min": 0.680875}, "location": {"width": 900, "top": 167, "height": 28, "left": 133}, "words": "者中,已出现2侧(1%;2200)间质性肺病/肺炎,其中1例为3级严重程度。无中国大陆患者死亡"}, {"probability": {"variance": 0.003509, "average": 0.971865, "min": 0.839443}, "location": {"width": 109, "top": 220, "height": 24, "left": 136}, "words": "QT间期延长"}, {"probability": {"variance": 0.000288, "average": 0.990983, "min": 0.922267}, "location": {"width": 898, "top": 246, "height": 26, "left": 173}, "words": "观测到QTe间期延长。先天性长QT综合征患者应避免服用克唑替尼胶囊。对于充血性心力衰竭、缓"}, {"probability": {"variance": 0.001692, "average": 0.990829, "min": 0.717858}, "location": {"width": 938, "top": 274, "height": 27, "left": 132}, "words": "慢性心律失常和电解质异常患者,以及正在服用已知可致QT间期延长药物的患者,使用本品治疗时应定"}, {"probability": {"variance": 0, "average": 0.999696, "min": 0.999406}, "location": {"width": 32, "top": 177, "height": 130, "left": 1149}, "words": "批件"}, {"probability": {"variance": 0.00081, "average": 0.987082, "min": 0.890724}, "location": {"width": 913, "top": 302, "height": 25, "left": 140}, "words": "期监测其心电图与电解质。旦出现4级Qc间期延长应永久停药;对于出现3级QTc间期延长的患者"}, {"probability": {"variance": 0.008568, "average": 0.969411, "min": 0.441383}, "location": {"width": 926, "top": 329, "height": 30, "left": 142}, "words": "暂停克唑替尼胶囊给药直至恢复至≤1级,继续用药200mg每日两次。3级QTe间期延长一旦复发,则暂"}, {"probability": {"variance": 0.000938, "average": 0.98623, "min": 0.88438}, "location": {"width": 943, "top": 358, "height": 28, "left": 132}, "words": "停给药直至恢复至≤1级,继续用药250mg,每日一次。若3级QTc间期延长再复发,则永久停药[参见用"}, {"probability": {"variance": 4.4e-05, "average": 0.996479, "min": 0.974029}, "location": {"width": 295, "top": 386, "height": 27, "left": 134}, "words": "法用量、不良反应和临床药理学"}, {"probability": {"variance": 1.8e-05, "average": 0.996749, "min": 0.985793}, "location": {"width": 166, "top": 438, "height": 27, "left": 135}, "words": "更新的安全性数据"}, {"probability": {"variance": 0.001347, "average": 0.985264, "min": 0.791907}, "location": {"width": 902, "top": 463, "height": 27, "left": 170}, "words": "截至2012年9月,在研究A8081001、A8081005以及A8081007中,已有2%(31/1354)的患者报告"}, {"probability": {"variance": 0.003901, "average": 0.984753, "min": 0.682617}, "location": {"width": 942, "top": 490, "height": 28, "left": 133}, "words": "治疗相关的心电图QT间期延长。在这些病例中,有14例(1%)为≥3,其中1例为4级严重程度。目前"}, {"probability": {"variance": 0.001226, "average": 0.988786, "min": 0.773806}, "location": {"width": 938, "top": 520, "height": 26, "left": 134}, "words": "未出现任何因心电图QT间期延长造成的死亡事件或患者永久停止研究药物。在中国大陆患者中,已出现"}, {"probability": {"variance": 0.003743, "average": 0.97484, "min": 0.706628}, "location": {"width": 642, "top": 547, "height": 26, "left": 133}, "words": "10例(5%10/200),其中5例为3级严重程度,未出现任何4级事件"}, {"probability": {"variance": 0.000155, "average": 0.98847, "min": 0.968135}, "location": {"width": 83, "top": 624, "height": 25, "left": 137}, "words": "ALK检测"}, {"probability": {"variance": 7.3e-05, "average": 0.997124, "min": 0.956877}, "location": {"width": 902, "top": 659, "height": 28, "left": 172}, "words": "在选择使用克唑替尼治疗的患者时,必须由受过培训的专业技术人员采用经充分验证过的检测方法诊"}, {"probability": {"variance": 0.00195, "average": 0.984014, "min": 0.714523}, "location": {"width": 944, "top": 690, "height": 25, "left": 132}, "words": "断为ALK阳性非小细胞肺癌( NSCLC)。在临床研究A8081005、A8081007及A8081014中使用的是雅"}, {"probability": {"variance": 0.000233, "average": 0.992538, "min": 0.940718}, "location": {"width": 889, "top": 717, "height": 25, "left": 132}, "words": "培公司的 Vysis ALK Break Apart FISH(荧光原位杂交)探针试剂盒。该试剂盒正在中国注册申报中"}, {"probability": {"variance": 0.002971, "average": 0.984898, "min": 0.695461}, "location": {"width": 902, "top": 756, "height": 26, "left": 173}, "words": "对非小细胞肺癌患者ALK阳性的评估应由在已证明可熟练使用该项技术的实验室进行。不正确的检"}, {"probability": {"variance": 6e-06, "average": 0.998472, "min": 0.991313}, "location": {"width": 312, "top": 783, "height": 26, "left": 133}, "words": "验操作可能产生不可信的检测结果"}, {"probability": {"variance": 3.3e-05, "average": 0.997813, "min": 0.978755}, "location": {"width": 236, "top": 852, "height": 26, "left": 139}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.000482, "average": 0.992588, "min": 0.892528}, "location": {"width": 906, "top": 891, "height": 27, "left": 171}, "words": "基于克唑替尼胶囊的作用机制,妊娠妇女服用可能会给胎儿带来伤害。目前尚无对妊娠妇女服用克唑"}, {"probability": {"variance": 0.00184, "average": 0.987441, "min": 0.777118}, "location": {"width": 942, "top": 918, "height": 27, "left": 133}, "words": "替尼胶囊进行足够的且良好对照的研究。在大鼠的非临床研究中,在暴露于近似或大于人体临床推荐剂量"}, {"probability": {"variance": 4.2e-05, "average": 0.99652, "min": 0.961569}, "location": {"width": 929, "top": 946, "height": 27, "left": 147}, "words": "250mg,每日两次)的情况下具有胚胎毒性和胎儿毒性。对器官形成期间的妊娠大鼠和家兔给予克唑替"}, {"probability": {"variance": 0.012536, "average": 0.967174, "min": 0.464997}, "location": {"width": 943, "top": 973, "height": 27, "left": 133}, "words": "尼,以研究药物对胚胎胎儿发育的影响。当大鼠用药为≥50mg/kg/天时(根据曲线下法为推荐人"}, {"probability": {"variance": 0.004664, "average": 0.981506, "min": 0.605842}, "location": {"width": 690, "top": 1001, "height": 27, "left": 140}, "words": "本临床用药剂量的1.2倍),出现着床后流产增加。当大鼠用药剂量达200m"}, {"probability": {"variance": 0.067628, "average": 0.749659, "min": 0.403696}, "location": {"width": 161, "top": 998, "height": 33, "left": 895}, "words": "根曲终积"}, {"probability": {"variance": 0.012479, "average": 0.965775, "min": 0.3628}, "location": {"width": 934, "top": 1025, "height": 31, "left": 142}, "words": "大约为推荐人体临床剂量时的5倍)或家兔用药剂量达60mg/kg/天(曲线下面积约为推荐人体临床量时"}, {"probability": {"variance": 7.3e-05, "average": 0.996164, "min": 0.960035}, "location": {"width": 495, "top": 1056, "height": 26, "left": 133}, "words": "的3倍)时,胚胎的体重有所降低,但未出现致畸作用"}, {"probability": {"variance": 0.0003, "average": 0.994491, "min": 0.913052}, "location": {"width": 518, "top": 1094, "height": 27, "left": 173}, "words": "育龄妇女在服用克唑替尼胶囊进行治疗时应尽量避免怀孕"}, {"probability": {"variance": 0.002821, "average": 0.988954, "min": 0.670941}, "location": {"width": 761, "top": 1133, "height": 28, "left": 174}, "words": "服用本药的育龄妇女或服用本药的育龄妇女的伴侣,在治疗过程中以及完成治疗至少"}, {"probability": {"variance": 0.007172, "average": 0.974274, "min": 0.549518}, "location": {"width": 943, "top": 1148, "height": 38, "left": 133}, "words": "适当的方法进行避孕。若在妊娠期间服本药,或患者或其伴侣在用药期间怀孕则应售知其品对胎儿"}, {"probability": {"variance": 2e-06, "average": 0.998368, "min": 0.995265}, "location": {"width": 124, "top": 1190, "height": 24, "left": 133}, "words": "具有潜在危害"}, {"probability": {"variance": 0, "average": 0.999369, "min": 0.99825}, "location": {"width": 102, "top": 1244, "height": 25, "left": 134}, "words": "哺乳期妇女"}, {"probability": {"variance": 1.6e-05, "average": 0.997779, "min": 0.980002}, "location": {"width": 662, "top": 1269, "height": 26, "left": 172}, "words": "目前尚不明确克唑替尼及其代谢物是否会从乳汁中分泌。由于多数药物通"}, {"probability": {"variance": 0, "average": 0.719735, "min": 0.719735}, "location": {"width": 80, "top": 1246, "height": 48, "left": 830}, "words": "药"}, {"probability": {"variance": 2e-05, "average": 0.997063, "min": 0.987507}, "location": {"width": 168, "top": 1271, "height": 31, "left": 911}, "words": "中分泌,以及"}, {"probability": {"variance": 6.9e-05, "average": 0.995529, "min": 0.958332}, "location": {"width": 798, "top": 1294, "height": 30, "left": 133}, "words": "婴儿若暴露于克唑替尼会发生潜在的严重不良反应,因此,决定哺乳期女是否终止哺乳"}, {"probability": {"variance": 0, "average": 0.999317, "min": 0.998842}, "location": {"width": 98, "top": 1299, "height": 24, "left": 980}, "words": "止用药非常"}, {"probability": {"variance": 0, "average": 0.992982, "min": 0.992855}, "location": {"width": 45, "top": 1328, "height": 23, "left": 133}, "words": "重要"}, {"probability": {"variance": 3e-06, "average": 0.998664, "min": 0.996283}, "location": {"width": 110, "top": 1392, "height": 25, "left": 141}, "words": "【儿童用药】"}, {"probability": {"variance": 0.004745, "average": 0.98096, "min": 0.536954}, "location": {"width": 905, "top": 1422, "height": 29, "left": 172}, "words": "目前尚无儿科患者使用克唑替尼胶囊的有效性和安全性数据研究发现,给予幼鼠克唑替尼150mg/kg"}, {"probability": {"variance": 0.007933, "average": 0.981724, "min": 0.465609}, "location": {"width": 706, "top": 1450, "height": 26, "left": 134}, "words": "天,每日一次,连续28天后(根据曲线下面积:大约为10倍的推荐人体临床"}, {"probability": {"variance": 2e-06, "average": 0.998792, "min": 0.996462}, "location": {"width": 165, "top": 1451, "height": 25, "left": 912}, "words": "其长骨生长过程中"}, {"probability": {"variance": 0.000227, "average": 0.99583, "min": 0.913414}, "location": {"width": 662, "top": 1477, "height": 27, "left": 133}, "words": "骨形成减少。关于几科患者的其他潜在毒性,尚未在幼年动物中进行评价"}, {"probability": {"variance": 2.2e-05, "average": 0.99669, "min": 0.986569}, "location": {"width": 111, "top": 1537, "height": 25, "left": 139}, "words": "【老年用药】"}, {"probability": {"variance": 0.001549, "average": 0.989162, "min": 0.729802}, "location": {"width": 888, "top": 1563, "height": 27, "left": 171}, "words": "本品临床研究并未入选足够例数的年龄为65岁或65岁以上患者,研究A8081005的136例患者中"}], "language": 3}